Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Revolution Medicines Inc.

    NASDAQ: RVMD · Real-Time Price · USD
    39.65
    -0.94 (-2.32%)
    At close: Jun 16, 2025, 3:59 PM
    39.77
    0.30%
    After-hours: Jun 16, 2025, 06:00 PM EDT

    Revolution Medicines Statistics

    Share Statistics

    Revolution Medicines has 186.27M shares outstanding. The number of shares has increased by 12.68% in one year.

    Shares Outstanding

    n/a
    		 186.27M

    Shares Change (YoY)

    n/a
    		 12.68%

    Shares Change (QoQ)

    n/a
    		 1.95%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 161.93M

    Failed to Deliver (FTD) Shares

    n/a
    		 79

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 18.36M, so 9.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 18.36M

    Short % of Shares Out

    n/a
    		 9.86%

    Short % of Float

    n/a
    		 10.49%

    Short Ratio (days to cover)

    n/a
    		 9.96

    Valuation Ratios

    The PE ratio is -12.23 and the forward PE ratio is -7.99. Revolution Medicines's PEG ratio is 1.69.

    PE Ratio

    n/a
    		 -12.23

    Forward PE

    n/a
    		 -7.99

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 4.9

    PB Ratio

    n/a
    		 3.24

    P/FCF Ratio

    n/a
    		 -12.92

    PEG Ratio

    n/a
    		 1.69
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Revolution Medicines.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 14.2, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 14.2

    Quick Ratio

    n/a
    		 14.2

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.23

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-974,176.95

    Employee Count

    n/a
    		 616

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 753K

    Effective Tax Rate

    n/a
    		 -0.13%

    Stock Price Statistics

    The stock price has increased by 6.87% in the last 52 weeks. The beta is 1.1, so Revolution Medicines's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.1

    52-Week Price Change

    n/a
    		 6.87%

    50-Day Moving Average

    n/a
    		 38.65

    200-Day Moving Average

    n/a
    		 43.48

    Relative Strength Index (RSI)

    n/a
    		 49.35

    Average Volume (20 Days)

    n/a
    		 1,840,977

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -689.52M

    Net Income

    n/a
    		 -600.09M

    EBITDA

    n/a
    		 -589.02M

    EBIT

    n/a
    		 -600.85M

    Earnings Per Share (EPS)

    n/a
    		 -3.58
    Full Income Statement

    Balance Sheet

    The company has 543.06M in cash and 135.84M in debt, giving a net cash position of 407.22M.

    Cash & Cash Equivalents

    n/a
    		 543.06M

    Total Debt

    n/a
    		 135.84M

    Net Cash

    n/a
    		 407.22M

    Retained Earnings

    n/a
    		 -1.74B

    Total Assets

    n/a
    		 2.37B

    Working Capital

    n/a
    		 1.98B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -557.44M and capital expenditures -10.31M, giving a free cash flow of -567.74M.

    Operating Cash Flow

    n/a
    		 -557.44M

    Capital Expenditures

    n/a
    		 -10.31M

    Free Cash Flow

    n/a
    		 -567.74M

    FCF Per Share

    n/a
    		 -3.38
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RVMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RVMD is $70, which is 76.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $70

    Price Target Difference

    n/a
    		 76.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 14.07

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist